Pharmaceutical combinations containing ponesimod

摘要

The present invention relates to a pharmaceutical combination comprising a first active ingredient which is ponesimod and a second active ingredient which is selected from the group consisting of teriflunomide and leflunomide. [Selection diagram] Fig. 1